From: Insulin use in Type 2 diabetic patients: a predictive of mortality in covid‑19 infection
Death | No death | p value | |
---|---|---|---|
Age, median [IQR] | 60 [54–62] | 57 [50–62] | 0.005 |
Gender, Male | 72 (84%) | 404 (66%) | 0.001 |
Intubation | 77 (90%) | 91 (15%) | < 0.001 |
PaO2/FiO2 | 141.5 (68.2–223) | 285 (191–448) | < 0.001 |
C- Reactive protein | 31.45 (21.8–42.2) | 16.3 (8.4–32.3) | < 0.001 |
D-dimer | 4673 (2111–12,447) | 639 (310–2460) | < 0.001 |
Ferritin | 2017 (1039–5043) | 881 (425–1618) | < 0.001 |
Procalcitonin | 5.25 (0.77–17.68) | 0.27 (0.11–0.7) | < 0.001 |
Acute kidney injury | 74 (86%) | 401 (66%) | < 0.001 |
Deep vein thrombosis | 12 (14%) | 34 (6%) | 0.003 |